TITLE:
Alternate-Day Buprenorphine Administration. Phase VIII - 9

CONDITION:
Opioid-Related Disorders

INTERVENTION:
Buprenorphine

SUMMARY:

      The purpose of this study is to evaluate open buprenorphine dosing with dose choice.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 25 Years to 48 Years
Criteria:

        Please contact site for information.
      
